SMTL ID : 4xoz.1

Crystal structure of ERK2 in complex with an inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 620: N~1~-[3-(benzyloxy)benzyl]-1H-tetrazole-1,5-diamine(Non-covalent)

620.1: 12 residues within 4Å: Chain A: A.43, K.45, I.47, T.59, E.62, I.63, I.94, Q.96, D.97, L.98, M.99, L.147 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.43, A:K.45, A:K.45, A:I.47, A:E.62, A:E.62, A:I.63, A:Q.96, A:Q.96 Hydrogen bonds: A:Q.96, A:D.97, A:M.99

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 4 residues within 4Å: Chain A: R.182, R.185, H.223, Y.224 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.182, A:R.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gelin, M. et al., Combining `dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. Acta Crystallogr.,Sect.D (2015)

Release Date

2015-08-12

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence